These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1834464)

  • 1. Antihypertensive drug therapy and regression of left ventricular hypertrophy: a review with a focus on diuretics.
    Moser M; Setaro JF
    Eur Heart J; 1991 Sep; 12(9):1034-9. PubMed ID: 1834464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy--a meta-analysis.
    Dahlöf B; Pennert K; Hansson L
    Clin Exp Hypertens A; 1992; 14(1-2):173-80. PubMed ID: 1347256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Up-dated treatment of arterial hypertension: progressive and individualized. Reduction of the heart mass].
    Rodríguez Padial L; Navarro Lima A; Aguilera Saldaña M; García Moreno LM; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():81-96. PubMed ID: 1970906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive therapy on diastolic dysfunction in left ventricular hypertrophy.
    Betocchi S; Chiariello M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S116-21. PubMed ID: 1381787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An evaluation of the therapeutic trials aimed at regression of ventricular hypertrophy in arterial hypertension].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):503-8. PubMed ID: 1836942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk reduction following regression of cardiac hypertrophy.
    Schmieder RE
    Clin Exp Hypertens A; 1990; 12(5):903-16. PubMed ID: 2145097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy and antihypertensive therapy.
    Messerli FH; Oren S; Grossman E
    Drugs; 1988; 35 Suppl 5():27-33. PubMed ID: 2975215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of myocardial and coronary effects of arterial hypertension].
    Strauer BE; Motz W; Vogt M
    Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regression of left ventricular hypertrophy with antihypertensive treatment].
    Galinier M; Bounhoure JP
    Presse Med; 1990 Nov; 19(37):1715-9. PubMed ID: 1979167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of increased left ventricular mass by antihypertensives.
    Lavie CJ; Ventura HO; Messerli FH
    Drugs; 1991 Dec; 42(6):945-61. PubMed ID: 1724641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regression of hypertensive cardiovascular changes during treatment with antihypertensive ddrugs].
    Schroeder AP; Pedersen OL
    Ugeskr Laeger; 1992 Nov; 154(46):3230-6. PubMed ID: 1462424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease.
    Strauer BE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S45-54. PubMed ID: 2468873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.